Participants 34 142 7
T cell subpopulations, NK activity, humoral immunity and leukocyte count in patients undergoing chemotherapy
Participants 204 334 4
T cell subpopulations, natural killer cell (NK) activity, humoral immunity and leukocyte count in patients undergoing chemotherapy
Participants 378 411 4
patients undergoing chemotherapy.
Participants 1081 1135 3
auxiliary therapy for patients undergoing chemotherapy
